Elekta increases customer focus with direct presence in Philippines
(MENAFN- Cision) STOCKHOLM, February 2, 2022 – Elekta (EKTA-B.ST) announced today that it has established an office in the Philippines’ capital, Manila, to offer new and existing customers superior service, education and training opportunities and faster access to the latest cancer care solutions. A direct presence in the country will allow Elekta to better address the Philippines’ large gap in access to radiation therapy and the huge patient backlog, caused in part by the Covid pandemic.
Habib Nehme, Elekta’s Executive Vice President of Turkey, India, Middle East, Africa, APAC & Japan, said: “Establishing an office in the Philippines is in line with our strategy of creating a world where everyone has access to the best cancer care. By being present in regional markets, we can be more responsive to the needs of our customers, which benefits their patients in these regions. Elekta is renowned for its breadth of cancer treatment solutions designed to fit any clinic, hospital or country.”
Although the World Health Organization estimates more than 153,000 new cancer cases per year in the Philippines,* this number can be addressed with adequate investment in radiation therapy equipment and software as well as education and training to meet the demand for trained clinicians. Elekta is prepared to meet these needs.
“Our ambition is to build a strong local organization with a focus on customer satisfaction,” said Shaun Seery, Elekta’s Senior Vice President Asia Pacific. “Elekta has seen good growth in the Philippines over the past decade, however the market remains underserved, and I know we can do more for our customers to become a competitive partner
MENAFN05022022005352011945ID1103644846
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.